Drugs / PF-06664178
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT02122146 | Aug 2014 → Jun 2016 | neoplasm | Pfizer | Terminated | No outcome recorded Stop: Business |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | PF-06664178 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02122146 ↗ |
| Route | Intravenous | “administered intravenously” NCT02122146 ↗ |